Ailogeneic hematopoietic cell transplantation for malignant hematological diseases in patients older than 50 years of age

Ailogeneic hematopoietic cell transplantation for malignant hematological diseases in patients older than 50 years of age

下载PDF

导出

摘要 Objective To investigate the efficiency and safety of allogeneic hematopoietic cell transplantation for malignant hematological diseases in patients older than 50 years of age. Methods From May 2002 to January 2010,35 patients P 】 50 years with malignant hematological diseases received allogeneic hematopoietic

作者吴小津

机构地区 Dept Hema-tol

出处《外科研究与新技术》 2011年第4期297-297,共1页 Surgical Research and New Technique

关键词 CELL Ailogeneic hematopoietic cell transplantation for malignant hematological diseases in patients older than 50 years of age THAN

分类号 R55 [医药卫生—血液循环系统疾病]

引文网络
相关文献

1唐佩弦.Current research in management of hematological diseases with poor prognosis[J].Chinese Medical Journal,2001(7):3-3.
2杨平.恶性高血压肾损害的26例临床分析[J].中外医疗,2009,28(26):56-56. 被引量：2
3夏凌辉,方峻,游泳,郭涛,刘芳,张纯,江汇娟,邹萍.Allogeneic Peripheral Blood Hematopoietic Stem Cell Transplantation for Patients with Hematologic Malignancies[J].Journal of Huazhong University of Science and Technology(Medical Sciences),2006,26(1):47-49. 被引量：5
4谢卫民,张婷婷,钟白云.异基因造血干细胞移植患者血清中AKP和-GT水平的变化及临床意义[J].现代检验医学杂志,2011,26(6):111-113.
5Deng W Han Q Liao L You S Deng H Zhao RC.Effects of allogeneic bone marrow-derived mesenchymal stem cells on T and B lymphocytes from BXSB mice[J].中国生物学文摘,2006,20(5):11-11. 被引量：1
6刘元生.恶性房颤(134)[J].临床心电学杂志,2015,24(5):396-396. 被引量：1
7李娅娜.慢性GVHD的辅助治疗和支持护理指南[J].中国医药导刊,2007,9(3):246-249. 被引量：1
8李琰.Effect and mechanisms of glycogen synthase kinase-3β （GSK-3β） on differentiation of malignant glioma cells[J].中国药理通讯,2009,26(2):12-12.
9鲁端.恶性心室早复极综合征的识别与处理[J].心电学杂志,2009(5):293-295. 被引量：8
10闫晨华.Epidemiology of febrile neutropenia in patients with hematological disease——a prospective multicentre survey in China[J].China Medical Abstracts(Internal Medicine),2016,33(2):53-54.

外科研究与新技术

2011年第4期

浏览历史

内容加载中请稍等...

Ailogeneic hematopoietic cell transplantation for malignant hematological diseases in patients older than 50 years of age

相关作者

相关机构

相关主题

浏览历史